UMH PROPERTIES, INC. TO PARTICIPATE IN NAREIT’S REITWEEK: 2024 INVESTOR CONFERENCE
May 28, 2024 16:07 ET
|
UMH Properties, Inc.
FREEHOLD, NJ, May 28, 2024 (GLOBE NEWSWIRE) -- UMH Properties, Inc. (NYSE:UMH) (TASE:UMH), today announced that the Company will participate in Nareit’s REITweek: 2024 Investor Conference, to be...
Micron Technology to Report Fiscal Third Quarter Results on June 26, 2024
May 28, 2024 16:01 ET
|
Micron Technology, Inc.
BOISE, Idaho, May 28, 2024 (GLOBE NEWSWIRE) -- Micron Technology, Inc. (Nasdaq: MU), announced today that it will hold its fiscal third quarter earnings conference call on Wednesday, June 26, 2024,...
Optinose to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
May 17, 2024 12:00 ET
|
Optinose, Inc.
YARDLEY, Pa., May 17, 2024 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced...
Webcast Alert: Cavco Industries, Inc. Announces Fiscal 2024 Fourth Quarter and Year End Earnings Release and Conference Call Webcast
May 15, 2024 20:50 ET
|
Cavco Industries, Inc.
PHOENIX, May 15, 2024 (GLOBE NEWSWIRE) -- Cavco Industries, Inc. (Nasdaq: CVCO) will release earnings for the fourth quarter and fiscal year ended March 30, 2024 on Thursday, May 23, 2024 after the...
Optinose Reports First Quarter 2024 Financial Results and Recent Operational Highlights
May 14, 2024 07:00 ET
|
Optinose, Inc.
Company reports Q1 2024 XHANCE net revenue of $14.9 million, an increase of 26% compared to Q1 2023 Company expects full year 2024 XHANCE net revenues to be between $85.0 to $95.0 million ...
Nano Dimension Announces Q1/2024 Conference Call to Discuss Quarterly Results
May 13, 2024 08:00 ET
|
Nano Dimension Ltd.
Participants Are Welcome to Listen June 3rd at 9:00 am ET Waltham, Mass., May 13, 2024 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (Nasdaq: NNDM, “Nano Dimension” or the “Company”), a leading...
Optinose Announces Reporting Date for First Quarter 2024 Financial Results
May 10, 2024 14:56 ET
|
Optinose, Inc.
YARDLEY, Pa., May 10, 2024 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced the...
CytoSorbents Reports First Quarter 2024 Results
May 09, 2024 16:17 ET
|
CytoSorbents
CytoSorbents Reports First Quarter 2024 Results
Cyclacel Pharmaceuticals to Release First Quarter 2024 Financial Results
May 08, 2024 09:15 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., May 08, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative...
Arbutus to Participate in Two Upcoming Investor Conferences
May 07, 2024 07:30 ET
|
Arbutus Biopharma Corporation
WARMINSTER, Pa., May 07, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a...